Evidence-based labor management: third stage of labor (part 5)
- PMID: 35537683
- DOI: 10.1016/j.ajogmf.2022.100661
Evidence-based labor management: third stage of labor (part 5)
Abstract
During the third stage of labor, oxytocin and tranexamic acid, oxytocin and misoprostol, oxytocin and methylergometrine, or carbetocin is recommended for the prevention of postpartum hemorrhage after vaginal delivery. Intravenous oxytocin (10 IU) immediately after delivery of the neonate (after either anterior shoulder or whole-body delivery) and before delivery of the placenta is recommended. If oxytocin and tranexamic acid combination is chosen, intravenous tranexamic acid (1 g) in addition to intravenous oxytocin (10 IU) immediately after delivery of the neonate and before placental delivery is recommended. If oxytocin and misoprostol combination is chosen, sublingual misoprostol (400 µg) in addition to intravenous oxytocin (10 IU) immediately after delivery of the neonate is recommended. If there is no intravenous access or if in low-resource settings, sublingual misoprostol (400 µg) and intramuscular oxytocin (10 IU) are recommended. If oxytocin and methylergometrine combination is chosen, intramuscular methylergometrine (0.2 mg) and intravenous oxytocin (10 IU) immediately after delivery of the neonate are recommended. Single-dose intravenous or intramuscular carbetocin (100 µg) immediately after delivery of the neonate is recommended. Controlled cord traction and delayed cord clamping for approximately 60 seconds is recommended. There is insufficient evidence to support or refute umbilical cord milking, uterine massage, or nipple stimulation for the prevention of postpartum hemorrhage. Repair of first- and second-degree lacerations with continuous synthetic suture technique is recommended. No repair of first-degree lacerations if hemostatic and normal cosmesis can be considered. Repair of third-degree lacerations with end-to-end or overlap continuous synthetic suture technique is recommended. Repair of fourth-degree lacerations with delayed absorbable 4-0 or 3-0 polyglactin or chromic suture in a running fashion is recommended. The use of single-dose second-generation cephalosporin at the time of third- or fourth-degree laceration repairs can be considered. Skin-to-skin contact after delivery is recommended. There is insufficient evidence to support or refute routine cord blood gas sampling after delivery. Public cord blood banking is recommended.
Keywords: controlled cord traction; evidence based; labor; methylergometrine; misoprostol; nipple stimulation; oxytocin; perineal lacerations; postpartum hemorrhage; skin to skin; systematic review; third stage; tranexamic acid; umbilical cord blood banking; umbilical cord clamping; umbilical cord gases; umbilical cord milking; uterine massage.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
Third stage of labor: evidence-based practice for prevention of adverse maternal and neonatal outcomes.Am J Obstet Gynecol. 2024 Mar;230(3S):S1046-S1060.e1. doi: 10.1016/j.ajog.2022.11.1298. Epub 2023 Aug 21. Am J Obstet Gynecol. 2024. PMID: 38462248 Review.
-
Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage.J Obstet Gynaecol Can. 2009 Oct;31(10):980-993. doi: 10.1016/S1701-2163(16)34329-8. J Obstet Gynaecol Can. 2009. PMID: 19941729 Review.
-
Prevention of postpartum hemorrhage in vaginal deliveries.Eur J Obstet Gynecol Reprod Biol. 2023 Jan;280:112-119. doi: 10.1016/j.ejogrb.2022.11.021. Epub 2022 Nov 24. Eur J Obstet Gynecol Reprod Biol. 2023. PMID: 36455391 Review.
-
Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor.Int J Gynaecol Obstet. 2009 Nov;107(2):130-4. doi: 10.1016/j.ijgo.2009.06.007. Epub 2009 Jul 22. Int J Gynaecol Obstet. 2009. PMID: 19628206 Clinical Trial.
-
Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial.Am J Obstet Gynecol. 2002 Oct;187(4):1038-45. doi: 10.1067/mob.2002.126293. Am J Obstet Gynecol. 2002. PMID: 12389002 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources